Thursday 24 November 2022

NOVEL Approach to Hyperphosphatemia

19:00

Welcome and Introduction
Jonathan Asprer

19:05

Critical role of phosphate binders in CKD-MBD management: Current state of evidence and practice
Daniel Coyne

19:45

An innovative strategy for management of hyperphosphatemia – Experience in Singapore
Behram Ali Khan

20:05

Scope of problem and novel treatments of hyperphosphatemia – Experience in Hong Kong
Desmond Yat Hin Yap

20:25

Q&A
ALL

20:45

Conclusion
Jonathan Asprer

Prof Daniel Coyne

  • Professor of Medicine in the Division of Nephrology, Department of Medicine
    at Washington University School of Medicine, St Louis, Missouri, USA
  • Director of the Medical Multispecialty Outpatient Group at the Center for
    Advanced Medicine, and Medical Director of the Chromalloy American Kidney
    Center at the Washington University School of Medicine
  • Editorial Board Member of the Journal of the American Society of Nephrology
    (JASN) from 2007-2010 and ad hoc reviewer of several journals including the
    American Journal of Kidney Diseases, American Journal of Nephrology and
    the New England Journal of Medicine
  • Author or co-author of >130 peer reviewed articles and 19 books and other
    publications

Dr Behram Ali Khan

  • Senior Consultant Nephrologist and Assistant Professor of Medicine
  • Received training in the USA and is American Board Certified in Nephrology
    and Internal Medicine
  • Serves as the Medical Director of The National Kidney Foundation Singapore,
    where he provides clinical governance to a multidisciplinary team of doctors,
    nurses and Allied Health staff at over 42 dialysis centres in Singapore
  • Continues his medical practice at the National University Hospital Singapore
    and his teaching/research activities at the National University of Singapore
    and Duke-NUS

Dr Desmond Yat Hin Yap

  • Clinical Associate Professor and honorary consultant and Deputy
    Chairperson (Teaching & Learning) in the Department of Medicine at the
    Queen Mary Hospital, the University of Hong Kong
  • Current major theme of research is immune-mediated glomerular diseases
    with emphasis on lupus nephritis, an important cause of renal failure,
    especially in Asia
  • Other research interests pertain to infective complications in renal failure
    patients, focusing on viral hepatitis in kidney transplant recipients and
    recently COVID-19 infection in renal patients
  • Co-first author of the Asian Guidelines for the management of lupus nephritis
    and contributor to the 2021 KDIGO Clinical Practice Guideline for
    Glomerulonephritis
  • Recipient of the 2021 Sir David Todd Lectureship from the Hong Kong
    College of Physicians for contributions to lupus nephritis research
  • Author or co-author of >120 peer reviewed articles and currently Subject
    Editor for the journal Nephrology